Sophion case stories
With the help of our automated patch clamp solutions, we have asked our customers how they use the technology to shape their future.
Case story: Making a difference through electrophysiology – QPatch Compact offers customized control over experiments
From QPatch to QPatch Compact – NMD Pharma breaks new ground in neuromuscular diseases
NMD Pharma is devoted to discovering and delivering life-transforming therapies for people living with neuromuscular diseases. As a research-based company, they are determined to be in control of their research and quality. Sophion’s automated patch clamp instruments have been a part of NMD Pharma’s research, and all the knowledge generated along the way has been an important part of NMD Pharma’s journey.
Case story: How automated patch clamp technology is playing a key role for B’SYS in delivering high-quality and reliable cell lines
State-of-the-art cell lines and flexible collaboration with experts in biomedical research
As a niche Contract Research Organization focused on ion channel discovery, offering the best service and customer satisfaction is always of the highest priority at B’SYS – and Sophion Bioscience’s automated patch clamp technology is playing a key role in their journey.
Case story: QPatch secured the best infrastructure for Linköping University’s new academic core facility
An academic core facility for a Swedish university – how QPatch ensured the best infrastructure
A high-throughput QPatch automated patch clamp instrument from Sophion Bioscience enabled Linköping University to accelerate its research into a new epilepsy drug – and to get the green light to build a national core facility for ion channel research.
Case story: Sophion technology helped Metrion Biosciences meet higher customer demands and growing assay complexity
Automated patch clamping – a silver bullet for higher customer demands and growing assay complexity
Metrion Biosciences successfully met the challenge of growing complexity in ion channel research by adopting Sophion Bioscience’s QPatch II and Qube 384 automated patch clamp platforms. The move transformed Metrion’s research output, enabling it to take on more – and larger – projects and grow its customer base.